These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9246699)

  • 1. Maintenance treatment for gastro-oesophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice.
    Venables TL; Newland RD; Patel AC; Hole J; Copeman MB; Turbitt ML
    Scand J Gastroenterol; 1997 Jul; 32(7):627-32. PubMed ID: 9246699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.
    Venables TL; Newland RD; Patel AC; Hole J; Wilcock C; Turbitt ML
    Scand J Gastroenterol; 1997 Oct; 32(10):965-73. PubMed ID: 9361167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
    Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
    Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esomeprazole: a review of its use in the management of acid-related disorders in the US.
    Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
    Drugs; 2002; 62(7):1091-118. PubMed ID: 11985491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a pectin-based anti-reflux agent on acid reflux and recurrence of symptoms and oesophagitis in gastro-oesophageal reflux disease.
    Havelund T; Aalykke C; Rasmussen L
    Eur J Gastroenterol Hepatol; 1997 May; 9(5):509-14. PubMed ID: 9187886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial.
    Wu JC; Chan FK; Ching JY; Leung WK; Hui Y; Leong R; Chung SC; Sung JJ
    Gut; 2004 Feb; 53(2):174-9. PubMed ID: 14724146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study.
    Laursen LS; Havelund T; Bondesen S; Hansen J; Sanchez G; Sebelin E; Fenger C; Lauritsen K
    Scand J Gastroenterol; 1995 Sep; 30(9):839-46. PubMed ID: 8578181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis.
    Richter JE; Peura D; Benjamin SB; Joelsson B; Whipple J
    Arch Intern Med; 2000 Jun; 160(12):1810-6. PubMed ID: 10871975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
    Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group.
    Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir DG; Gillon KR; Peacock RA; Fulton C
    BMJ; 1999 Feb; 318(7182):502-7. PubMed ID: 10024259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.
    Galmiche JP; Barthelemy P; Hamelin B
    Aliment Pharmacol Ther; 1997 Aug; 11(4):765-73. PubMed ID: 9305487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis.
    Bate CM; Green JR; Axon AT; Murray FE; Tildesley G; Emmas CE; Taylor MD
    Aliment Pharmacol Ther; 1997 Aug; 11(4):755-63. PubMed ID: 9305486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years.
    Thjodleifsson B; Rindi G; Fiocca R; Humphries TJ; Morocutti A; Miller N; Bardhan KD;
    Aliment Pharmacol Ther; 2003 Feb; 17(3):343-51. PubMed ID: 12562446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial.
    Lind T; Havelund T; Lundell L; Glise H; Lauritsen K; Pedersen SA; Anker-Hansen O; Stubberöd A; Eriksson G; Carlsson R; Junghard O
    Aliment Pharmacol Ther; 1999 Jul; 13(7):907-14. PubMed ID: 10383525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group.
    Carlsson R; Dent J; Watts R; Riley S; Sheikh R; Hatlebakk J; Haug K; de Groot G; van Oudvorst A; Dalväg A; Junghard O; Wiklund I
    Eur J Gastroenterol Hepatol; 1998 Feb; 10(2):119-24. PubMed ID: 9581986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment.
    Bytzer P; Morocutti A; Kennerly P; Ravic M; Miller N;
    Scand J Gastroenterol; 2006 Oct; 41(10):1132-40. PubMed ID: 16990197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of omeprazole in lower grades of gastro-oesophageal reflux disease.
    Havelund T; Laursen LS; Lauritsen K
    Scand J Gastroenterol Suppl; 1994; 201():69-73. PubMed ID: 8047827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD; Wilde MI
    Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial.
    Schwizer W; Thumshirn M; Dent J; Guldenschuh I; Menne D; Cathomas G; Fried M
    Lancet; 2001 Jun; 357(9270):1738-42. PubMed ID: 11403809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esomeprazole: a review of its use in the management of acid-related disorders.
    Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
    Drugs; 2002; 62(10):1503-38. PubMed ID: 12093317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.